Actively Recruiting
Tirbanibulin for Pediatric Warts
Led by The Skin Center Dermatology Group · Updated on 2026-04-23
10
Participants Needed
1
Research Sites
86 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Warts are common, benign skin lesions caused by the human papillomavirus (HPV). Treatment is challenging, particularly in the pediatric population, where standard modalities such as cryotherapy and intralesional immunotherapy are poorly tolerated. Existing topical treatments, such as imiquimod and 5-fluorouracil, have low efficacy and require prolonged use. Case reports suggest tirbanibulin ointment may provide an effective and well-tolerated alternative for pediatric warts. This study will evaluate the efficacy and safety of tirbanibulin ointment in treating pediatric hand warts.
CONDITIONS
Official Title
Tirbanibulin for Pediatric Warts
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 8 to 18 years
- Ability of the participant and their legal representative to understand and follow study requirements and provide informed consent/assent
- Participant judged to be in good health based on screening and medical history
- Diagnosis of warts on the hands
- Wart count on the hands between 3 and 10
You will not qualify if you...
- Wart duration longer than 2 years
- More than 10 warts outside the hands
- Total wart surface area on the hands larger than 100 cm2
- Prior failure of treatment with intralesional immunotherapy, intralesional bleomycin, 5-fluorouracil, methotrexate, or cidofovir
- Use of any wart treatment (over-the-counter, prescription, or in-office) within 6 weeks before baseline
- Known immunosuppression from disease or medication
- Known allergy to any ingredient in the investigational product
- Any condition that may interfere with the study as judged by the Principal Investigator
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
The Skin Center Dermatology Group
New City, New York, United States, 10956
Actively Recruiting
Research Team
P
Peter Friedman, MD, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here